Supermarket shopping data reveals that many women reach for suboptimal pain relief when tackling period cramps, according to new analysis by BBC Health.
The data suggests consumers gravitate toward over-the-counter options that don't target menstrual pain as effectively as alternatives. Ibuprofen and naproxen, both nonsteroidal anti-inflammatory drugs (NSAIDs), rank among the most effective treatments for dysmenorrhea because they specifically address inflammation tied to uterine contractions. Yet purchasing patterns indicate women often buy paracetamol instead, which provides general pain relief but lacks NSAID's targeted anti-inflammatory action.
The gap between what works and what people actually buy points to several factors. Branding matters. Paracetamol products dominate shelf space in many retailers and benefit from stronger marketing presence. Price plays a role too. Paracetamol typically costs less, nudging budget-conscious shoppers toward the cheaper option despite inferior efficacy for period pain specifically.
Accessibility compounds the problem. Many women don't know which medication suits their needs best. Healthcare providers rarely explain the pharmacological differences between pain relievers, leaving consumers to guess based on advertising or family habit. Some also worry about NSAID side effects, even at standard doses, creating unnecessary hesitation around more effective options.
The findings carry implications beyond individual shopping carts. When women choose ineffective treatments, they suffer longer and more intensely. This feeds into normalized suffering around menstruation, a cultural pattern that discourages seeking better solutions. Some then escalate to prescription-strength medication when simpler changes to over-the-counter choices could help.
Public health messaging could shift purchasing behavior. Clear guidance from doctors and pharmacists explaining why NSAIDs outperform paracetamol for period cramps would empower informed choices. Retailers could improve product placement and labeling to highlight which medications target menstrual pain. Until then, many women remain trapped in a cycle of buying what they see rather than what actually works.